Monica Popov, MD
Obstetrics & Gynecology · Denton, TXNPI 1922004340
Payments from drug & device makers
Across 52 payments — averaging $50.44 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Myriad Women's Health, Inc.$2K
- AbbVie$194
- Astellas Pharma US Inc$148
- Applied Medical Resources Corporation$137
- Monaghan Medical Corporation$74
- Organon$65
- plus $429 from 17 others
What the payments were for
- Speaking & faculty fees$1,57560%
- Travel & lodging$80%
- Food & beverage$84932%
- Education$1917%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Myriad Women's Health, Inc. | 3 | $1,575 |
| AbbVie | 11 | $194 |
| Astellas Pharma US Inc | 4 | $148 |
| Applied Medical Resources Corporation | 3 | $137 |
| Monaghan Medical Corporation | 5 | $74 |
| Organon | 4 | $65 |
| Intuitive Surgical | 3 | $65 |
| Johnson & Johnson | 3 | $52 |
| Avion Pharmaceuticals | 2 | $34 |
| Amgen | 1 | $32 |
| Avanos Medical | 1 | $29 |
| Mayne Pharma Commercial LLC | 1 | $28 |
| Medtronic | 1 | $27 |
| Bayer | 1 | $20 |
| Agile Therapeutics, Inc. | 1 | $19 |
| Biogen | 1 | $19 |
| Smith+Nephew | 1 | $17 |
| Cook Medical LLC | 1 | $17 |
| Pfizer | 1 | $16 |
| LSI Solutions Inc | 1 | $15 |
| Covidien LP | 1 | $14 |
| Minerva Surgical, Inc | 1 | $14 |
| Merck | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- myRisk$1,575
How this compares
$2,623 in reported general payments places this provider in the 70th percentile of 3,099 obstetrics & gynecology providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Estradiol | 168 | $10,733 |
| Estradiol (Twice Weekly)Estradiol | 33 | $3,695 |
| Estradiol (Once Weekly)Estradiol | 21 | $1,298 |
| ProgesteroneProgesterone, Micronized | 28 | $1,014 |
| Clobetasol EmollientClobetasol Propionate/Emoll | 12 | $619 |
| ValacyclovirValacyclovir Hcl | 15 | $559 |
| Clobetasol Propionate | 12 | $148 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 11 | $85 |
Paid to pharmacies, not to this prescriber.
Other obstetrics & gynecology in Denton
- Sangeetha VulichiDenton$414K
- Amir JazaeriHouston$19.5M
- Shannon WestinHouston$17.3M
- Monica LopezFort Worth$8.1M
- Cynthia RobbinsFort Worth$7.8M
- John Paul RobertsPlano$4.9M
- Stephen StamatisWeatherford$4.5M
- Parke HedgesSan Antonio$4.2M
- Mary MartinBeaumont$2.8M
- Mark JacobsHouston$2.8M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.